Biolinq
PrivateLast Round
Series C
Apr 22, 2025
Est. Valuation
$405M
Total Funding Raised
$214.75M
Company Overview
Biolinq is a healthcare technology company that develops a wearable biosensor platform for continuous monitoring of metabolic health, including glucose, ketones, and lactate.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Sensors, Biotechnology
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biolinq Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Biolinq Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 22, 2025 | ||||
| VC Round | Apr 4, 2024 | ||||
| Series B | Nov 2, 2021 | ||||
| Series A Extension | Mar 28, 2019 | ||||
| Series A | Nov 27, 2017 |
Key People
Founding team and executive leadership
Biolinq Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Senvest Capital | Series B |
| Grey Sky Venture Partners | Series A |
| LifeSci Venture Partners | Series C, Series A, Series A Extension |
| Aphelion Capital | Series C, VC Round, Series B, Series A Extension |
| Able Partners | Series B |
| Senvest Management | VC Round, Series B |
| Longevity Vision Fund | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2025
Job posting discloses that Biolinq is a clinical stage medical device company, indicating its biosensor platform is undergoing clinical trials.
- Apr 22, 2025
Raised $100M in Series C funding.
Biolinq Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Biolinq's valuation, stock price, and market status.